1. Home
  2. LGCB vs CMND Comparison

LGCB vs CMND Comparison

Compare LGCB & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGCB

Linkage Global Inc

HOLD

Current Price

$1.47

Market Cap

17.1M

Sector

N/A

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$0.64

Market Cap

1.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGCB
CMND
Founded
2011
2017
Country
Japan
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
1.4M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
LGCB
CMND
Price
$1.47
$0.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.0K
104.0K
Earning Date
01-30-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.07
52 Week High
$3.10
$3.25

Technical Indicators

Market Signals
Indicator
LGCB
CMND
Relative Strength Index (RSI) 42.02 27.33
Support Level $1.43 $0.08
Resistance Level $2.23 $1.11
Average True Range (ATR) 0.09 0.12
MACD -0.01 -0.01
Stochastic Oscillator 20.00 12.03

Price Performance

Historical Comparison
LGCB
CMND

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: